indican has been researched along with Diabetes Mellitus, Adult-Onset in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 6 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CH; Chang, KT; Huang, YC; Ko, PH; Lai, LC; Tsai, TC | 1 |
| Douguchi, S; Hosoya, M; Katoh, M; Ofuchi, K; Osonoi, T; Saito, M | 1 |
| Aliasgharzadeh, A; Jouyban, A; Moradi, M; Oladi-Ghadikolaei, R; Shayanfar, A; Soleymani, J; Tayebi Khosroshahi, H | 1 |
| Balint, L; Bob, F; Cretu, OM; Gadalean, F; Glavan, M; Ienciu, S; Jianu, DC; Milas, O; Mogos, M; Petrica, L; Socaciu, AI; Socaciu, C; Suteanu-Simulescu, A; Vlad, A | 1 |
| Arakawa, S; Bamba, T; Fukusaki, E; Furuno, M; Katakami, N; Matsuoka, TA; Ninomiya, H; Omori, K; Shimomura, I; Takahara, M; Tsugawa, H; Yamamoto, Y | 1 |
| Arakawa, S; Bamba, T; Fukusaki, E; Furuno, M; Katakami, N; Matsuoka, TA; Omori, K; Shimomura, I; Takahara, M; Taya, N; Tsugawa, H | 1 |
| Chen, CK; Chen, CY; Chou, CC; Hsu, HJ; Hsu, KH; Lee, CC; Sun, CY; Tsai, CJ; Wu, IW; Wu, MS; Yen, CH | 1 |
| Avance, J; Denson, D; Harris, R; Stec, DF; Stothers, C; Voziyan, P; Wang, S | 1 |
| Barrios, C; Beaumont, M; Bell, JT; Clark, A; Goodrich, JK; Ley, RE; Menni, C; Pallister, T; Pascual, J; Spector, TD; Villar, J | 1 |
| Bao, Y; Gao, P; Hong, CS; Jia, W; Luo, P; Tu, Y; Wei, L; Xu, G; Yin, P; Yu, H; Zhang, P; Zhao, X; Zhuang, Z | 1 |
| Atoh, K; Haneda, M; Itoh, H | 1 |
| Aoyama, I; Niwa, T | 1 |
12 other study(ies) available for indican and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Indoxyl Sulfate Elevated Lnc-SLC15A1-1 Upregulating CXCL10/CXCL8 Expression in High-Glucose Endothelial Cells by Sponging MicroRNAs.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Chemokine CXCL10; Diabetes Mellitus, Type 2; Endothelial Cells; Female; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Indican; Male; MicroRNAs; Middle Aged; Peptide Transporter 1; Renal Insufficiency, Chronic; Toxins, Biological; Up-Regulation | 2021 |
Efficacy and safety of switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, in hyperuricemic patients with type 2 diabetic kidney disease: Protocol for a single-arm, open-label, prospective, exploratory study.
Topics: Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Substitution; Febuxostat; Humans; Hyperuricemia; Indican; Prospective Studies; Uric Acid; Uricosuric Agents | 2022 |
Serum Levels of Indoxyl Sulfate and P-cresol in Type II Diabetic Patients With and Without Nephropathy.
Topics: Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Indican; Proteinuria; Uric Acid | 2023 |
Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients.
Topics: Arginine; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Gastrointestinal Microbiome; Humans; Indican; Metabolomics; Sulfates | 2023 |
Identification of Plasma Inositol and Indoxyl Sulfate as Novel Biomarker Candidates for Atherosclerosis in Patients with Type 2 Diabetes. -Findings from Metabolome Analysis Using GC/MS.
Topics: Aged; Atherosclerosis; Biomarkers; Carotid Intima-Media Thickness; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Gas Chromatography-Mass Spectrometry; Humans; Indican; Inositol; Japan; Male; Metabolome; Metabolomics; Middle Aged; Myocardial Ischemia; Solvents | 2020 |
Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes.
Topics: Aged; Ankle Brachial Index; Biomarkers; Diabetes Mellitus, Type 2; Erythritol; Female; Gas Chromatography-Mass Spectrometry; Humans; Indican; Male; Mannitol; Metabolomics; Middle Aged; Peripheral Arterial Disease; Pyrrolidonecarboxylic Acid; Vascular Stiffness | 2020 |
The association of uremic toxins and inflammation in hemodialysis patients.
Topics: Aged; Comorbidity; Coronary Artery Disease; Creatinine; Cresols; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Humans; Indican; Inflammation; Inflammation Mediators; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Sulfuric Acid Esters | 2014 |
Alterations of urinary metabolite profile in model diabetic nephropathy.
Topics: Aconitic Acid; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glycine; Hippurates; Indican; Keto Acids; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Phenylacetates | 2015 |
Gut-Microbiota-Metabolite Axis in Early Renal Function Decline.
Topics: Adult; Aged; Aged, 80 and over; Body Mass Index; Clostridiales; Cresols; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diseases in Twins; Feces; Female; Fermentation; Gastrointestinal Microbiome; Glomerular Filtration Rate; Glutamine; Humans; Indican; Kidney Diseases; Male; Metabolome; Microbiota; Middle Aged; Ribotyping; Sulfuric Acid Esters | 2015 |
Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.
Topics: Adult; Amino Acids; Bile Acids and Salts; Bilirubin; Biomarkers; Carnitine; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Energy Metabolism; Fatty Acids, Nonesterified; Female; Gastric Bypass; Hippurates; Humans; Indican; Insulin Resistance; Male; Mass Spectrometry; Metabolomics; Middle Aged; Obesity, Morbid; Oxidative Stress; Prognosis; Remission Induction; Treatment Outcome; Tryptophan; Weight Loss | 2016 |
Serum indoxyl sulfate levels in patients with diabetic nephropathy: relation to renal function.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diagnostic Techniques, Endocrine; Disease Progression; Female; Glomerular Filtration Rate; Humans; Indican; Kidney; Kidney Failure, Chronic; Male; Middle Aged | 2009 |
An oral adsorbent ameliorates renal overload of indoxyl sulfate and progression of renal failure in diabetic rats.
Topics: Administration, Oral; Animals; Blood Urea Nitrogen; Carbon; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Immunohistochemistry; Indican; Kidney; Kidney Failure, Chronic; Kidney Glomerulus; Male; Oxides; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Treatment Outcome; Triglycerides | 2001 |